Zevra Therapeutics, Inc. (ZVRA) earnings
ZVRA earnings moved a median of +1.11% by the close. Quarterly and annual ZVRA reports and results, each read against the price at its own news timestamp. Back to the ZVRA overview →
23 measured ZVRA earnings events.
Where these ZVRA earnings landedvs 23 measured ZVRA earnings reactions
| Middle 50% of ZVRA earnings reactions | -4.24% to +3.25% |
|---|---|
| Median reaction (to close) | +1.11% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 ZVRA earnings events with a measured close landed between -4.24% and +3.25%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.51% | +1.11% | |
| Zevra Reports Second Quarter 2026 Financial Results and Corporate Update | Press release | +0.51% | +1.11% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +1.06% | +1.29% | |
| Zevra Reports First Quarter 2026 Financial Results and Corporate Update | Press release | +1.06% | +1.29% | |
| Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +1.32% | +1.00% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.56% | -4.32% | |
| Zevra Reports Third Quarter 2025 Financial Results and Corporate Update | Press release | -1.56% | -4.32% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | -1.50% | -8.80% | |
| Zevra Reports Second Quarter 2025 Financial Results and Corporate Update | Press release | -1.50% | -8.80% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.59% | -4.24% | |
| Zevra Reports First Quarter 2025 Financial Results and Corporate Update | Press release | -0.59% | -4.24% | |
| Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +5.49% | +1.28% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +3.61% | +8.14% | |
| Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates | Press release | +3.59% | +7.18% | |
| Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024 | Press release | -1.13% | -2.75% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +2.23% | +4.17% | |
| Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights | Press release | +2.23% | +4.17% | |
| Zevra Therapeutics to Report Second Quarter 2024 Financial Results | Press release | -1.19% | -6.30% | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.81% | -2.63% | |
| Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates | Press release | +0.83% | +6.61% | |
| Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024 | Press release | +0.65% | -0.43% | |
| Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results | Press release | +6.86% | +2.33% | |
| Zevra Therapeutics to Report Third Quarter 2023 Results on November 7, 2023, at 8:00 a.m. ET | Press release | +2.33% | +4.19% |
Keep exploring
More ZVRA: analyst actions → · SEC filings → · ZVRA overview →